According to the DCF models I have seen from a couple of the analysts, FDA full approval value for wAMD and DME is $9 per share and $3 per share. Approx.
- Forums
- ASX - By Stock
- OPT
- Ann: Opthea Reports Positive Ph2a Trial Results of OPT-302 in DME
Ann: Opthea Reports Positive Ph2a Trial Results of OPT-302 in DME, page-109
-
- There are more pages in this discussion • 16 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
Featured News
Add OPT (ASX) to my watchlist
(20min delay)
|
|||||
Last
79.5¢ |
Change
0.010(1.27%) |
Mkt cap ! $984.8M |
Open | High | Low | Value | Volume |
78.5¢ | 80.5¢ | 78.5¢ | $131.2K | 165.2K |
Buyers (Bids)
No. | Vol. | Price($) |
---|---|---|
12 | 6246 | 79.5¢ |
Sellers (Offers)
Price($) | Vol. | No. |
---|---|---|
80.0¢ | 13541 | 13 |
View Market Depth
No. | Vol. | Price($) |
---|---|---|
6 | 1228 | 0.795 |
9 | 18143 | 0.790 |
7 | 14835 | 0.785 |
6 | 34975 | 0.780 |
4 | 61273 | 0.775 |
Price($) | Vol. | No. |
---|---|---|
0.800 | 19954 | 15 |
0.805 | 19036 | 8 |
0.810 | 22732 | 10 |
0.815 | 33188 | 5 |
0.820 | 35972 | 4 |
Last trade - 11.15am 08/11/2024 (20 minute delay) ? |
Featured News
OPT (ASX) Chart |
The Watchlist
EQN
EQUINOX RESOURCES LIMITED.
Zac Komur, MD & CEO
Zac Komur
MD & CEO
SPONSORED BY The Market Online